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among these dose points were calculated. Statistical 
correlation between the nine FP and TP dose points were 
studied by using correlation coefficient (r). We compared the 
strength of correlation obtained using different geometry and 
iterations. The goodness of mimicking function was evaluated 
in terms of DVHs similarity: minimum euclidean distances 
between the FP versus TP DVHs curves were calculated. For 
every ROI we obtained an index that is the average minimum 
distance of sample points of the curve. The total DVH index 
of the plan is the sum of single ROI indices. 
Results: The r-values always being >0.8 indicated a strong 
correlation between the %DD of reference plan and converted 
ones. However a statistically significant difference between 
the strength of correlation obtained using a different number 
of iterations has been observed ( 80 vs 40 (p=0.02), 40 vs fall 
(p=0.007), 80vsfall (p=0.002)). A statistical dependence with 
number of arcs was observed (2 vs 4 arcs (p=0.02)). However 
the number of iterations has a greater influence on dose 
distribution than number of arcs. The average calculated of 
DVH indices were strongly correlated with the r coefficients 
(r=-0.85). The plan with 4 arcs and 80 iterations was the 
more like the original reference plan (average %DD=0.1% for 
targets , 1.2% for OARs and the smallest DVH index).  
Conclusions: The fallback module is capable of creating 
plans with high plan quality, ensuring a high level of 
flexibility in clinical practice. The new tool based on average 
distance of DVH curves is a quick way to compare the 
different distributions taking into account not only of specific 
dose points. Combining fallback and DVH index, for every 
plan 'manually' created, plans with alternative treatment 
techniques could automatically and therefore rather 
effortless be created and compared with the original plan.  
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Purpose/Objective : To demonstrate that the structure of 
the HU to relative stopping power (RSP) conversion curve 
(the number of linear segments and their relative slope) 
contributes to an increase of the proton range systematic 
error in presence of a zero-mean Gaussian CT noise. To our 
knowledge this effect has never been highlighted before 
although it has a potential impact in the precision of proton 
therapy plans. 
Materials and Methods: The RSP bias and uncertainty profiles 
as a function of the CT number and the noise standard 
deviation have first been analytically derived for the case of 
a calibration curve composed of an arbitrary number of linear 
segments. This has led to the definition of an effective 
conversion curve given by the mathematical expectation of 
the RSP which better describes the effect of noise on its 
statistics.  
The equations of the CSDA range bias and uncertainty have 
then been obtained from the RSP probability density function 
for a phantom either homogeneous or composed of a finite 
number of well separated materials. The main idea behind 
the latter case is to evaluate to which extend the range 
systematic error is still significant when different materials 
along the proton path have potentially compensating effects.  
These theoretical results have been validated against CSDA 
simulations of a 1D homogeneous volume for different 
materials, noise standard deviation, proton energy and 
computational grid size. Supplementary Monte-Carlo (MC) 
simulations have also been performed with 3D volumes. 
Results: The results for two typical conversion models with 
different slopes in their positive HU segment are presented 
here. The figure below shows the evolution with HU noise (1% 
being 10 HU of standard deviation) of the analytical range 
bias and uncertainty for 160 MeV protons and three 
materials: water, adipose AP6 and inner bone IB1.  
The material with the highest bias, i.e. water, is the one 
with the closest HU distance to the slope discontinuity. Its 
bias is about 0.5 mm at 4%, i.e. in the upper limit of random 
noise levels for CT. It reaches 1 mm at 6%, a typical cone-
beam CT noise level. The systematic error decreases with the 
relative distance to the discontinuity and increases with the 
slope difference. The range uncertainty increases 
quadratically with the slope. CSDA and MC simulations have 
shown to have very close behaviors and amplitudes even for 




Conclusions: Both analytical and simulated results prove that 
the RSP and therefore the range have statistics which 
strongly depend on the shape of the HU-RSP conversion 
curve. The effect on range has been evaluated in terms of 
bias and uncertainty which have been shown not to be 
negligible with a typical bias of 0.5 mm. 
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Purpose/Objective: Realizing an ultra-fast, highly accurate 
CPU-based Monte Carlo (MC) dose calculation framework 
optimized for modern parallel processor architectures. 
Materials and Methods: A new Monte Carlo dose calculation 
framework PhiMC is presented which implements the Dose 
Planning Method (DPM) engine for modern shared-memory 
CPUs. A significant runtime speed-up is achieved by exploit 
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multiple levels of parallelism offered by modern CPUs : 
Thread-level parallelism (TLP) is provided by expanding the 
particle transport physics to multiple CPU cores. On this 
level, the MC simulation is embarrassingly parallel so that 
each core runs its own simulation. However, gathering energy 
deposition events into one dose cube is challenging and needs 
to be orchestrated carefully using a buffered memory 
streaming technique. Data-level parallelism is achieved be 
re-engineering vital parts of the engine for Singe Instruction 
Multiple Data (SIMD) registers. Portability between a wide 
range of CPU generations is achieved by using APIs such as 
OpenMP, Cilk Plus and Intel MKL. PhiMC includes a source 
model for the dose delivery system and is capable of 
simulating clinical IMRT cases in the required spatial 
resolution of the dose grid. PhiMC has been implemented in 
C++ and the accuracy of the algorithms is validated against 
the original DPM framework using the Two One-Sided 
statistical Test (TOST) procedure. 
Results: We could show that the dose values calculated with 
PhiMC and DPM coincide at levels of 100% (for electrons) and 
99.7% (for photons) with a significance level of 0.05. 900 
million particle histories in water sampled from a 6 MV 
photon spectrum can be simulated in 47.3 seconds with a 
mean uncertainty of 0.32% on a dual Xeon workstation. An 
IMRT prostate plan with 9 beams and a voxel resolution of 
(1.95 x 1.95 x 2.0) mm³ could be simulated with 150 million 
histories in 16.2 seconds achieving a mean statistical 
uncertainty of 0.86%. A head&neck patient case using 9 
beams and a voxel resolution of (1.56 x 1.56 x 3.0) mm³ can 
be simulated in 8.2 seconds with an uncertainty of 0.89%. 
Conclusions: The dose of typical clinical IMRT plans can be 
simulated in less than 20 seconds with a mean uncertainty of 
less than 1% with our CPU-based PhiMC dose calculation 
framework. Compared to a GPU-based implementation of 
DPM (gDPM), PhiMC achieves better runtime results. In 
addition to that, a CPU implementation is not limited to a 
few GB of RAM and can therefore simulate larger plans or 
plans with a higher resolution.  
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Purpose/Objective: A knowledge-based planning (KBP) 
algorithm was recently implemented into a commercial 
treatment planning system. The objective of this work was to 
evaluate the impact of training set plan quality on the ability 
of the KBP software to produce a high quality head and neck 
(HN) DVH prediction model and to validate the KBP model for 
clinical use. 
Materials and Methods: The KBP software was used to create 
an initial model for HN patients using a training set of 149 
plans from our clinical database. The training set included 
bilateral/unilateral, definitive and post-operative HN cases 
with arange of simultaneously integrated boost prescription 
dose levels determined from the clinical diagnosis. DVH 
prediction models were trained for the brain, brainstem, 
esophagus, larynx, lips, oral cavity, parotid glands, 
pharyngeal constrictors, spinal cord, and submandibular 
glands. Optic structures were excluded from the modeling 
process due to small structure volume and standard maximum 
dose objectives were used for optimization. The quality of 
each plan in the training cohort was assessed by comparing 
the clinically-approved DVHs to the DVHs predicted by the 
initial model. This method was used to identify dosimetric 
outliers where the clinical DVHs were sub-optimal to the 
predicted DVHs. Identified outliers (Table 1) were removed 
from the training set to create a refined model. A randomly 
selected 20 patient validation cohort was used to evaluate 
the impact of training set plan quality on the output of the 
DVH prediction model. This impact was assessed by 
comparing clinically relevant DVH metrics (mean dose or 
maximum dose) predicted by the refined model to those 
predicted by the initial model. The accuracy of the refined 
model to achieve predicted DVH values was evaluated by 
comparing DVH metrics predicted by the refined model to 
DVH metrics achieved in a replan using the refined HN model. 
Clinical acceptability was evaluated by comparing the DVH 
metrics in the clinically approved plan to the KBP model 
replan. 
Results: There was a a reduction in the average predicted 
mean/maximum dose in the refined model compared to the 
initial model (Table 1) for all structures included in the 
model. The refined HN model demonstrated excellent 
predictive accuracy, with a small average difference between 
clinical metrics of the KBP modal replan and the refined DVH 
predictions (Table 1). The ability of the HN model to produce 
clinically acceptable plans was demonstrated in the 20 
validation patients by similar clinical metrics achieved 





Conclusions: This study validates that the developed KBP 
model systematically produces clinically acceptable plans for 
HN patients. The results demonstrate the impact of training 
